- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Bret Jackson Discusses Upcoming Challenges of Paying for Specialty Drugs, Therapeutic Advancements
A major upcoming challenge in healthcare will be determining how to pay for specialty drugs and medical advancements like cellular therapies, said Bret Jackson, president of the Economic Alliance for Michigan.
A major upcoming challenge in healthcare will be determining how to pay for specialty drugs and medical advancements like cellular therapies, said Bret Jackson, president of the Economic Alliance for Michigan.
Transcript
There are a number of new policies and proposals coming from the Trump administration. Are there any specific ones that you are excited about or concerned about?
I guess we’re waiting to see what sticks, because as you said, there’s a number of different proposals that are being submitted and kind of thrown out into the ether to see what happens. I don’t know if any of them are going to become meaningful, and until they do it’s really hard to judge what type of impact they’ll have on the healthcare marketplace.
For the organizations you work with in Michigan, are there any particular new health issues they’re concerned about?
I think the trends that we’re seeing with specialty drugs, which are known problems, are the problems that are coming up and going to be the future issues that we have to deal with in healthcare. All of these cellular therapies and genomic testing and all of these wonderful advancements in healthcare also come at an extremely high cost, and we have to figure out how we’re going to manage that going forward.
BCI Shows Promise of Personalized Endocrine Therapy in Breast Cancer
January 15th 2025The Breast Cancer Index (BCI) may help identify patients with low-risk breast cancer who could potentially benefit from reduced endocrine therapy, leading to improved quality of life and potentially lower health care costs.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Patient-Reported QOL Outcomes of Initial CLL Treatments: ASH 2024
January 8th 2025Quality-of-life (QOL) outcomes vary widely for patients receiving first-line treatment for chronic lymphocytic leukemia (CLL), according to research presented at the 2024 American Society of Hematology (ASH) meeting.
Read More
